Inaktiver Wert

Andere Sprachen Lion Biotechnologies Inc OTC Bulletin Board

Aktien

LBIO

US53619R1023

LBIO

Schlusskurs OTC Bulletin Board Andere Börsenplätze
- ^USD	-

13.05.	IOVANCE BIOTHERAPEUTICS, INC. : Truist Securities bekräftigt seine Kaufempfehlung	ZM
13.05.	IOVANCE BIOTHERAPEUTICS, INC. : erhält Kaufen-Rating von Truist Securities	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	17.05.
Small lymphocytic lymphoma Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)	14.05.
Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says	10.05.
Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates	10.05.
Iovance Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
Iovance Biotherapeutics Q1 Loss Narrows -- Shares Higher After Hours	09.05.
Iovance Biotherapeutics: Q1 Earnings Snapshot	09.05.
Earnings Flash (IOVA) IOVANCE BIOTHERAPEUTICS Posts Q1 Revenue $715,000	09.05.
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates	09.05.
Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024	01.05.
Iovance Biotherapeutics to Present at Upcoming Conferences	30.04.
Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting	24.04.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(4) - April 19, 2024	22.04.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	19.04.
General (Ret.) Merrill A. McPeak, Member of the Board of Directors of Iovance Biotherapeutics, Inc. Retires and Not Stands for Re-Election	29.03.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(4)	25.03.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	22.03.
Iovance Biotherapeutics to Present at Upcoming Conferences	04.03.
Sector Update: Health Care Stocks Lean Lower Pre-Bell Monday	04.03.
Iovance Biotherapeutics Says FDA Lifts Partial Clinical Hold on Lung Cancer Study	04.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Lion Biotechnologies Inc OTC Bulletin Board

Aktien

LBIO

US53619R1023

LBIO

Andere Sprachen

Filter